FMP
NASDAQ
1.82 USD
0.04 (2.2%)
Mr. Ilan Hadar M.B.A.
Healthcare
Drug Manufacturers - Specialty & Generic
https://www.painreform.com
NASDAQ
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
0001801834
IL0011651580
M77798102
65 Yigal Alon Street
972 3 717 7050
IL
7
Sep 1, 2020
0001801834
NASDAQ
Drug Manufacturers -...
Healthcare
M77798102
IL0011651580
IL
1.82
0.53
21.33k
3.15M
-
0.417-26.41
6.07
-
-
-
-
-0.25
-
https://www.painreform.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.